Home › Diffuse Scleroderma › South Carolina › Charleston
Diffuse Scleroderma clinical trials in Charleston, SC
3 studies for Diffuse Scleroderma are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Medical University of South Carolina (MUSC), Charleston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Charleston, Charleston
Diffuse Scleroderma trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Chicago, IL5 studies
- Kansas City, KS4 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Houston, TX3 studies
- New Orleans, LA3 studies
Other studies in Charleston
- Stroke19 studies
- Depression18 studies
- Post-Traumatic Stress Disorder16 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Heart Failure16 studies
- Non-Small Cell Lung Cancer16 studies
- Prostate Cancer16 studies
- Cardiovascular Disease16 studies
- Cancer (all types)14 studies
- Parkinson's Disease13 studies
- Breast Cancer12 studies
- Lung Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.